This is feline leukemia protection like you’ve never seen before. Non-adjuvanted PUREVAX^® Recombinant Leukemia Vaccine and the VET JET™ transdermal vaccination system enhance immune response¹ through targeted antigen presentation.

Here’s what makes this vaccine the advanced choice in feline leukemia protection:

• The only non adjuvanted Feline leukemia vaccine
• Recombinant canarypox vector vaccine technology uses only the specific genetic material necessary to induce immunity^2,3
• Stimulation of humoral and cell-mediated immune response¹
• Enhanced immune response through immediate transdermal exposure to dendritic cells¹
• Lower volume dosage (0.25 mL)